UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients’ Survival

BioMed research international, 2018-01, Vol.2018 (2018), p.1-9

2018

Volltextzugriff (PDF)

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Journal of clinical oncology, 2019-06, Vol.37 (16), p.1412-1423

2019

Volltextzugriff (PDF)

Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer

BJU international, 2015-12, Vol.116 (6), p.873-879

2015

Volltextzugriff (PDF)

MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men

BioMed research international, 2015-01, Vol.2015 (2015), p.1-6

2015

Volltextzugriff (PDF)

Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma

PloS one, 2013-09, Vol.8 (9), p.e76386-e76386

2013

Volltextzugriff (PDF)

Prognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus Level

BioMed research international, 2015-01, Vol.2015 (2015), p.1-8

2015

Volltextzugriff (PDF)

Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma

PloS one, 2014-07, Vol.9 (7), p.e102262-e102262

2014

Volltextzugriff (PDF)

Ist das Testosteron-Management beim fortgeschrittenen hormonsensitiven Prostatakarzinom zeitgemäß?

Aktuelle Urologie, 2022-02, Vol.53 (1), p.37-42

2022

Volltextzugriff (PDF)

Dendritic Cell-Based Immunotherapy for Prostate Cancer

Clinical & developmental immunology, 2010-01, Vol.2010 (2010), p.1-8

2010

Volltextzugriff (PDF)

MP20-20 BETTER PREDICTION OF TUMOR AGGRESSIVENESS IN MRI/ULTRASOUND-FUSION-BIOPSY COMPARED TO SYSTEMATIC PROSTATE BIOPSY

The Journal of urology, 2018-04, Vol.199 (4), p.e261-e261

2018

Volltextzugriff (PDF)

Impact of resection margin status after nephron‐sparing surgery for renal cell carcinoma

BJU international, 2006-06, Vol.97 (6), p.1208-1210

2006

Volltextzugriff (PDF)

PD51-03 PREDICTING COMPETING MORTALITY IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY AT AN AGE OF 70 YEARS OR OLDER

The Journal of urology, 2017, Vol.197 (4), p.e985-e985

2017

Volltextzugriff (PDF)

MP21-07 SELECTION EFFECTS MAY EXPLAIN SMOKING-RELATED OUTCOME DIFFERENCES AFTER RADICAL CYSTECTOMY

The Journal of urology, 2017-04, Vol.197 (4), p.e250-e250

2017

Volltextzugriff (PDF)

Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography‐fusion biopsy

BJU international, 2016-08, Vol.118 (2), p.213-220

2016

Volltextzugriff (PDF)

Management of testosterone in advanced hormone-sensitive prostate cancer: still up to date?

Aktuelle Urologie, 2022-02, Vol.53 (1), p.37

2022

Volltextzugriff (PDF)

Advances in renal cell carcinoma treatment

Therapeutic Advances in Urology, 2010-02, Vol.2 (1), p.11-17

2010

Volltextzugriff (PDF)

Predicting Competing Mortality in Patients Undergoing Radical Prostatectomy Aged 70 yr or Older

European urology, 2017-05, Vol.71 (5), p.710-713

2017

Volltextzugriff (PDF)

MP57-12 PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN PATIENTS WITH PREVIOUSLY NEGATIVE PROSTATE BIOPSY UNDERGOING MRI/ULTRASOUND-FUSION BIOPSY IN COMBINATION WITH SYSTEMATIC BIOPSY

The Journal of urology, 2018-04, Vol.199 (4), p.e769-e769

2018

Volltextzugriff (PDF)

MP12-04 ONLY LESS THAN 10% OF PATIENTS SELECTED FOR RADICAL PROSTATECTOMY REACH THE COMPETING MORTALITY RATE OF THE PROSTATE CANCER INTERVENTION VERSUS OBSERVATION TRIAL (PIVOT)

The Journal of urology, 2018-04, Vol.199 (4), p.e136-e136

2018

Volltextzugriff (PDF)

Growth of a Level III Vena Cava Tumor Thrombus Within 1 Month

Urology (Ridgewood, N.J.), 2016-04, Vol.90, p.e1-e2

2016

Volltextzugriff (PDF)

Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy‐naïve patients

BJU international, 2018-01, Vol.121 (1), p.53-60

2018

Volltextzugriff (PDF)

MP18-02 EVALUATION OF MRI/ULTRASOUND-FUSION BIOPSY IN PATIENTS WITH LOW-RISK PROSTATE CANCER UNDER ACTIVE SURVEILLANCE

The Journal of urology, 2017-04, Vol.197 (4), p.e219-e220

2017

Volltextzugriff (PDF)

PD51-03 PREDICTING COMPETING MORTALITY IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY AT AN AGE OF 70 YEARS OR OLDER

The Journal of urology, 2017-04, Vol.197 (4), p.e985-e985

2017

Volltextzugriff (PDF)

PD43-01 ASSESSMENT OF TUMOUR-AGGRESSIVENESS IN TRANSPERINEAL MRI/ULTRASOUND-FUSION BIOPSY IN COMPARISON TO TRANSRECTAL SYSTEMATIC PROSTATE BIOPSY IN PATIENTS WITH AND WITHOUT PRIOR BIOPSY

The Journal of urology, 2017-04, Vol.197 (4), p.e817-e817

2017

Volltextzugriff (PDF)

Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project)

European urology, 2013-09, Vol.64 (3), p.472-477

2013

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Aktive Filter

KollektionSpringerNature Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(102)
Japanisch
(6)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients’ Survival

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer

MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men

Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma

Prognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus Level

Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma

Ist das Testosteron-Management beim fortgeschrittenen hormonsensitiven Prostatakarzinom zeitgemäß?

Dendritic Cell-Based Immunotherapy for Prostate Cancer

MP20-20 BETTER PREDICTION OF TUMOR AGGRESSIVENESS IN MRI/ULTRASOUND-FUSION-BIOPSY COMPARED TO SYSTEMATIC PROSTATE BIOPSY

Impact of resection margin status after nephron‐sparing surgery for renal cell carcinoma

PD51-03 PREDICTING COMPETING MORTALITY IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY AT AN AGE OF 70 YEARS OR OLDER

MP21-07 SELECTION EFFECTS MAY EXPLAIN SMOKING-RELATED OUTCOME DIFFERENCES AFTER RADICAL CYSTECTOMY

Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography‐fusion biopsy

Management of testosterone in advanced hormone-sensitive prostate cancer: still up to date?

Advances in renal cell carcinoma treatment

Predicting Competing Mortality in Patients Undergoing Radical Prostatectomy Aged 70 yr or Older

MP57-12 PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN PATIENTS WITH PREVIOUSLY NEGATIVE PROSTATE BIOPSY UNDERGOING MRI/ULTRASOUND-FUSION BIOPSY IN COMBINATION WITH SYSTEMATIC BIOPSY

MP12-04 ONLY LESS THAN 10% OF PATIENTS SELECTED FOR RADICAL PROSTATECTOMY REACH THE COMPETING MORTALITY RATE OF THE PROSTATE CANCER INTERVENTION VERSUS OBSERVATION TRIAL (PIVOT)

Growth of a Level III Vena Cava Tumor Thrombus Within 1 Month

Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy‐naïve patients

MP18-02 EVALUATION OF MRI/ULTRASOUND-FUSION BIOPSY IN PATIENTS WITH LOW-RISK PROSTATE CANCER UNDER ACTIVE SURVEILLANCE

PD51-03 PREDICTING COMPETING MORTALITY IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY AT AN AGE OF 70 YEARS OR OLDER

PD43-01 ASSESSMENT OF TUMOUR-AGGRESSIVENESS IN TRANSPERINEAL MRI/ULTRASOUND-FUSION BIOPSY IN COMPARISON TO TRANSRECTAL SYSTEMATIC PROSTATE BIOPSY IN PATIENTS WITH AND WITHOUT PRIOR BIOPSY

Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project)

Aktive Filter

Suchergebnisse filtern